Spero Therapeutics, Inc. (SPRO)
2.26
+0.07
(+3.20%)
USD |
NASDAQ |
Mar 04, 13:15
Spero Therapeutics Total Assets (Quarterly) : 54.17M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Amicus Therapeutics, Inc. | 949.87M |
| Cassava Sciences, Inc. | 129.73M |
| Alpha Teknova, Inc. | 103.58M |
| Pyxis Oncology, Inc. | 105.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.68M |
| Shareholders Equity (Quarterly) | 26.49M |
| Debt to Equity Ratio | 0.1265 |
| Current Ratio | 3.834 |
| Net Debt Paydown Yield | 0.30% |